Research ArticleCancer

Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies

See allHide authors and affiliations

Science Translational Medicine  09 Jun 2010:
Vol. 2, Issue 35, pp. 35ra41
DOI: 10.1126/scitranslmed.3000758

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article